iRadimed Corporation (IRMD) Social Stream
IRADIMED CORP (IRMD) Price Targets From Analysts
Use the tables below to see what analysts covering IRADIMED CORP think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued July 29, 2022
The Trend in the Analyst Price Target
Over the past 18 months, IRMD's average price target has gone up $14.
Over the past 45 weeks, IRMD's average upside potential has been 12%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
IRMD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, IRMD's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- IRADIMED CORP's number of analysts covering the stock is higher than practically none of all US stocks.
- IRADIMED CORP's variance in analysts' estimates is lower than almost 100% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, IRADIMED CORP's average analyst price target is greater than 257.84% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, IRADIMED CORP's upside potential (average analyst target price relative to current price) is greater than 77.07% of them.
Is IRMD a Buy, Hold or Sell? See the POWR Ratings now!